1. Cartilage damage and synovial toxicokinetic study of a sustained release liposomal formulation of dexamethasone sodium phosphate (TLC599) following intra-articular injection in healthy dogs and rabbits. (April 2019) Authors: YU, W.-N.; Wu, M.-J.; Chang, P.-C.; Shih, S.-F. Journal: Osteoarthritis and cartilage Issue: Volume 27(2019)Supplement 1 Page Start: S161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Single intra-articular injection of TLC599 in patients with osteoarthritis knee pain: subgroup analyses of a placebo-controlled 24-week phase 2 trial. Issue 1 (April 2020) Authors: Brown, C.; Wu, C.-F.; Chuang, W.; Shih, S.-F. Journal: Osteoarthritis and cartilage Issue: Volume 28:Issue 1(2020)supplement Page Start: S481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Single intra-articular injection of TLC599 provided sustained pain relief through 24 weeks in participants with symptomatic knee osteoarthritis. (April 2019) Authors: Hunter, D.; Chang, C.-C.; Wei, J.-C.; Lin, H.-Y.; Brown, C.; Shih, S.-F. Journal: Osteoarthritis and cartilage Issue: Volume 27(2019)Supplement 1 Page Start: S87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗